Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

April 12, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

April 17, 2019

Conditions
Alzheimer Disease
Interventions
DRUG

ID1201

Trial Locations (20)

Unknown

Dong-A University Hospital, Busan

Changwon Fatima Hospital, Changwon

Kangwon National University Hospital, Chuncheon

Daegu Catholic University Medical Center, Daegu

Kyungpook National University Chilgok Hospital, Daegu

Yeungnam University Medical Center, Daegu

Daejeon Eulji Medical Center, Eulji University, Daejeon

Myongji Hospital, Goyang

Hanyang University Guri Hospital, Guri-si

Chonnam National University Hospital, Gwangju

Inha University Hospital, Incheon

Chonbuk National University Hospital, Jeonju

Seoul National University Bundang Hospital, Seongnam-si

Chung-Ang University Hospital, Seoul

Ewha Womans University Mokdong Hospital, Seoul

Hanyang University Hospital, Seoul

Korea University Anam Hospital, Seoul

KunKuk University Hospital, Seoul

Ajou University Medical Center, Suwon

Pusan National University Yangsan Hospital, Yangsan

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT03363269 - Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease | Biotech Hunter | Biotech Hunter